Publication | Closed Access

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma

Surgical OncologyOncologyPancreatic CancerGastrointestinal OncologyMedicineRandomised Phase 2PathologyPancreatic SurgeryCancer TreatmentPharmacologyRadiation OncologyMolecular Oncology